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Abstract Renin is the first and rate-limiting step of the
renin-angiotensin system. The exclusive source of renin in
the circulation are the juxtaglomerular cells of the kidney,
which line the afferent arterioles at the entrance of the
glomeruli. Normally, renin production by these cells suf-
fices to maintain homeostasis. However, under chronic
stimulation of renin release, for instance during a low-salt
diet or antihypertensive therapy, cells that previously
expressed renin during congenital life re-convert to a renin-
producing cell phenotype, a phenomenon which is known
as ‘‘recruitment’’. How exactly such differentiation occurs
remains to be clarified. This review critically discusses the
phenotypic plasticity of renin cells, connecting them not
only to the classical concept of blood pressure regulation,
but also to more complex contexts such as development
and growth processes, cell repair mechanisms and tissue
regeneration.
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1 Introduction
The renin-angiotensin system (RAS) plays a central role
in blood pressure regulation and fluid-electrolyte home-
ostasis. It involves an array of enzymes, peptides and
receptors with endocrine, paracrine and autocrine func-
tions, whose actions are able to correct small extracellular
volume (ECV) variations by increasing or decreasing
RAS activity. According to the classical, endocrine view
of the RAS, also known as the systemic RAS, renin,
synthesized in the kidneys, catalyzes cleavage of a
10-amino acid peptide, angiotensin I, from the N-terminus
portion of the circulating angiotensinogen, a protein pro-
duced by the liver. This decapeptide is subsequently
hydrolyzed by angiotensin I-converting enzyme (ACE), a
dicarboxyl-peptidase ubiquitously present on the plasma
membrane of endothelial cells, yielding the octapeptide
angiotensin II, the active end product of the RAS cascade,
which is responsible, among others, for sodium reab-
sorption in the proximal convolute tubule of the nephron,
and for vessel constriction, especially arterioles within the
renal and systemic circulation [1]. This traditional axis
was completed later, with the discovery of aldosterone.
Angiotensin II stimulates the zona glomerulosa in the
adrenal cortex to release aldosterone, which promotes
sodium reabsorption coupled with potassium exchange in
the distal convolute tubule of the nephron. The whole
axis, named renin-angiotensin-aldosterone system
(RAAS), is now firmly linked to ECV adjustment and
blood pressure regulation [2]. However, in the last three
decades, the RAS has assumed an even bigger role, in
that it also participates in the pathophysiology of renal
and cardiovascular diseases, through its inflammatory and
pro-fibrotic actions. As a consequence, RAS blockade
now is a cornerstone in the treatment of renal and car-
diovascular diseases [3, 4]. The RAS also contributes to
normal and abnormal growth processes and, evolutionary,
the growth-promoting actions of angiotensin precede its
endocrine and paracrine effects, representing one of its
most highly conserved functions [5].
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2 Renin
In 1898, Tigerstedt and Bergman performed a set of
experiments, where they observed a rise in blood pressure
after injecting rabbit kidney extracts in the jugular vein of
rabbits. They characterized the substance as derived from
the renal cortex, soluble in water and alcohol, thermolabile,
and named it ‘‘renin’’. This discovery remained dormant
for more than 40 years, until a few decades ago research
finally started to focus on renin [6]. Renin represents the
first and the rate-limiting step of the RAS cascade. Over-
production and underproduction of renin result in severe
disturbances of body fluid homeostasis. Precise regulation
of renin release is therefore indispensable for proper RAS
functioning [1, 7]. Renin is an aspartyl protease synthe-
sized as an inactive zymogen, prorenin. The kidney
secretes both renin and prorenin, but plasma levels of
prorenin are, under normal conditions, about tenfold higher
than the plasma levels of renin [8]. Renin consists of two
homologous lobes, with a cleft in between, which contains
the active site. Prorenin has a 43-amino acid N-terminal
propeptide, which covers the enzymatic cleft between the 2
lobes, thereby preventing the access of its specific sub-
strate, angiotensinogen. Prorenin is a glycoprotein, which
can be activated in two ways: proteolytically or non-pro-
teolytically. The former is irreversible and involves
removal of the propeptide by a processing enzyme, while
the latter is reversible, inducible by certain conditions such
as low temperature and pH, and results from a conforma-
tional alteration, i.e., unfolding of the propeptide from the
enzymatic cleft [9].
3 Juxtaglomerular Cells (JGC)
The JGC of the kidney are the only source of renin and
the main source of prorenin in the circulation [1, 10].
Several extrarenal tissues, such as the adrenal gland,
ovary, testis, placenta and retina, additionally produce and
secrete prorenin [8]. Indeed, after a bilateral nephrectomy,
prorenin, but not renin, can still be detected at low levels
in blood [11]. Following its synthesis, prorenin enters the
Golgi apparatus to be glycosylated, and then proceeds to
one of two different pathways. The first one involves
clear vesicles containing prorenin which are secreted
constitutively, while the second pathway involves pro-
renin tagging for regulated secretion, which is accompa-
nied by proteolytic prorenin-renin conversion, and renin
storage in dense cytoplasmic granules [10], awaiting
release in response to various stimuli, such as a sudden
fall in blood pressure, a low salt diet, or b-adrenergic
stimulation [12].
JGC are part of the juxtaglomerular apparatus, a tight
structure situated on the kidney glomerular hilum, composed
mainly of specialized epithelial cells (macula densa cells of
the ascending limb of the nephron loop), extraglomerular
mesangial cells, the terminal portion of the afferent arterioles
and the proximal portion of the efferent arterioles. JGC are
within these vessels and exhibit an epithelioid appearance,
with a prominent endoplasmic reticulum, Golgi apparatus,
and renin granules, but also containing myofibrils and
adhesion plaques, typical of smooth muscle cells [13].
Efforts to characterize JGC have historically been
hampered by several factors: JGC lose their secretory
granules and, concomitantly, their ability to proteolytically
activate prorenin when placed in culture [14]; JGC make
up approximately 1/1000 of the total cell mass of the
kidney, making it difficult to isolate sufficient quantities of
pure cells for further characterization [15].
4 JGC Progenitors and their Embryology
JGC represent one type of the so-called repertoire of renin-
producing cells (RPC), a group of cells that at some
moment in their lifespan produce renin. During kidney
ontogeny in mammals, renin expression changes according
to a pattern (Fig. 1). It first appears in the undifferentiated
metanephric blastema before vessel formation has begun.
Once the vascularization begins, around the 14th embry-
onic day in mice and rats, RPC are distributed along the
walls of the arteriolar vessels. As the process evolves, renin
starts to be expressed in other cells along the distal portions
of the newly formed vessels. Gradually, RPC disappear
from the larger vessels, shifting toward the afferent arte-
rioles, and, finally, assuming their position on the juxta-
glomerular apparatus [12]. Gomez et al. showed that the
ontogeny of renin expression by RPC depicts its own
phylogenetic evolution pattern [16].
The expression of the renin gene is tissue-specific and
developmentally regulated [17]. Renal renin concentrations
are high in early life, decreasing progressively as kidney
maturation evolves [18]. During this process, RPC are
associated with assembling and branching of the develop-
ing kidney vasculature [19], and the ablation of these cells
in mice during development results in a distinct kidney
phenotype with peculiar vascular abnormalities [20].
In vivo, vascularization of the kidney is synchronized with
epithelial nephrogenesis [21]. Epithelial branching mor-
phogenesis is critical for the formation of various organs,
including the vasculature and kidneys [22]. The definitive
kidney in mammals originates from a complex interaction
between the ureteric bud and the metanephric mes-
enchyme, both derived from the intermediate mesoderm.
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These reciprocal actions lead the ureteric bud to elongate
and bifurcate toward the metanephric mesenchyme, form-
ing on its tip, an aggregate of mesenchyme cells, the cap
mesenchyme. This condensate of cells generates a vesicle,
which continues to form a comma-shaped body and later, a
S-shaped body that gives rise to most of glomerulus and
tubular epithelia. As nephrogenesis progresses, the newly
formed S-shaped body is fused to the ureteric bud, from
which the collecting ducts and ureter originate [23, 24].
Cap mesenchyme expresses the transcriptional factors
Six2 and Cited1 and gives rise to Bowman’s capsule,
podocytes, the proximal and distal convolute tubules and
the loop of Henle. There is an outer layer of loose mes-
enchyme cells, adjacent to the cap mesenchyme, which
expresses different transcriptional factors: cKit (endothelial
precursors) or forkhead box D1 (FoxD1, stromal cells). The
latter factor is responsible for the generation of RPC,
mesangial cells and all mural cells, including vascular
smooth muscle cells (VSMC), perivascular fibroblasts and
pericytes [25–27].
5 The Recruitment Phenomenon
JGC lineage involves differentiation of the above meta-
nephric mesenchymal cells. This complex process gener-
ates hemangioblasts, which will evolve to endothelial cells,
and RPC precursors, the latter harboring the transcriptional
factor FoxD1. During kidney ontogeny, these precursors
will give rise to JGC and a subset of VSMC [25, 27]. In the
Fig. 1 Schematic illustration of
nephrogenesis. The ureteric bud
(UB) interacts with the
methanephric mesenchyme
(MM), resulting in the
subsequent formation of the cap
mesenchyme (CM) and loose
mesenchyme (LM). The CM
harbors the transcription factors
Six2 and Cited1 (in orange),
and will give rise to the tubular
system (proximal convolute
tubule (PCT), loop of Henle
(LH) and distal convolute tubule
(DCT); the LM harbors the
transcriptions factor FoxD1
(depicted in green), and will
give rise to most of the
glomeruli and vascular cells
from the afferent arteriole (AA)
and efferent arteriole (EA). The
UB will evolve to from the
collecting duct (CD) and ureter.
Modified from [21, 24, 33]
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adult, stress events that threaten body homeostasis, such as
hypotension or extracellular fluid depletion, are normally
corrected through renin release by JGC. Nevertheless, if
this response does not suffice, or if renin expression is
chronically stimulated, VSMC along the preglomerular
arterioles undergo metaplasia to a renin cell phenotype in
order to also synthesize renin, a phenomenon known as
‘‘recruitment’’ [28] (Fig. 2). Importantly, the upregulation
of renin synthesis and release following a homeostasis
threat is due to a rise in the number of RPC (hyperplasia)
rather than an elevation on the renin production per cell
(hypertrophy) [29, 30].
The recruitment phenomenon is an indispensible
mechanism to maintain homeostasis. In the 1970s, Cantin
et al. observed metaplasia of VSMC into JGC in the
arteries and arterioles of ischemic kidneys [31]. Nowadays,
it is known that this transformation involves differentiation
of a non-renin-expressing cell into a phenotype that is able
to synthesize renin, and occurs in the descendants of cells
that previously expressed renin during development [32].
Interestingly, once the stimulation perpetuates, the
recruitment intensifies, and RPC may occur all along the
extension of preglomerular arterioles, larger vessels, in the
extraglomerular and intraglomerular mesangium, in a pat-
tern that resembles the development of the embryonic
kidney [32]. In a recent review, Gomez emphasized that
recruitment does not involve migration or replication of
cells, but solely concerns a phenotype switch toward renin
expression by cells whose capability to produce renin is
latent, and re-acquired following appropriate stimulation
[33].
Nevertheless, Dzau et al. identified liver X receptor
alpha (LXRa), a nuclear receptor, as an important player in
the induction of renin expression in JGC. They showed that
LXRa exerts its activity as a cAMP-responsive regulator,
binding to a unique upstream region of the renin promoter
[34]. LXRa activation additionally upregulated a set of
genes (e.g., c-myc) that are involved in cellular differen-
tiation, proliferation and migration. Accordingly, LXRa
would induce JGC hypertrophy and hyperplasia, through
its coordinate interaction on the renin and c-myc promoters
[29].
Moreover, mesenchymal stem cells (MSC) have also
been suggested to play a pivotal role in the recruitment
phenomenon. Matsushita et al. demonstrated that human
and murine MSC are capable of synthesizing renin fol-
lowing LXRa activation. Indeed, MSC overexpressing
LXRa and under continuous cAMP stimulation underwent
differentiation to a RPC phenotype, which could also
express a-smooth muscle actin (aSMA) [35]. Thus, on the
basis of these findings, it was speculated that MSC, which
are normally resident within the glomerulus, might be the
Fig. 2 The ‘recruitment’ phenomenon, illustrated by a schematic
illustration (a, c) and immunofluorescence and fluorescent in situ
hybridization data from control and captopril-treated mice (b, d,
modified from [64]). In adult kidneys, renin is produced by the
juxtaglomerular (JG) cells located within the afferent arterioles at the
entrance of the glomeruli. However, under chronic renin stimulation
(e.g., following captopril treatment), renin lineage cells [like the
vascular smooth muscle cells (VSMC)] along the afferent arterioles
may convert into a renin-producing cell (RPC) phenotype in order to
maintain the homeostasis
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origin of the RPC [35]. Wang et al. used cell lineage
tracking models to further study the role of MSC in RPC
recruitment. First, they isolated MSC from the adult mouse
kidney and verified the expression of typical tissue stem/
progenitor cell markers, including CD44, and of meta-
nephric mesenchymal cell markers, such as FoxD1. CD44-
positive MSC-like cells differentiated into RPC following
exposure to an LXRa agonist, cAMP or a phosphodi-
esterase inhibitor [36]. Furthermore, mice submitted to a
low salt diet and captopril treatment, conditions well-
established to induce JGC recruitment, exhibited an
expansion of RPC in the kidney, accompanied by CD44
cells, with co-localization of MSC markers and renin.
These results could not be reproduced with bone marrow
MSC, suggesting that only MSC resident in the adult kid-
ney contribute to JGC recruitment [36]. The prostaglandin
E2/E-prostanoid receptor 4 pathway, also known for its
involvement in tubuloglomerular feedback, played a key
role in the activation of renal CD44-positive MSC during
conditions of JGC recruitment [37].
However, the participation of adult renal MSC in JGC
recruitment has been questioned. Gomez et al. reported that
MSC at most have a very minor contribution in comparison
with the already existing pool of arteriolar cells undergoing
a phenotype switch [33]. The latter authors ascertained that
JGC also express CD44, so that it is questionable whether
MSC truly represent a different cell group in the recruit-
ment process, or are just simply descendants of the renin
cell lineage, capable of switching their renin phenotype
back and forth. Moreover, CD44 expression on MSC might
be an in vitro artifact, since primary MSC from bone
marrow lacked such expression, while it did occur after
culturing the cells [38]. Further studies are needed to
unravel the precise role of MSC in JGC recruitment.
6 cAMP Pathway and Recruitment
Renin is a cAMP-inducible gene. In all species tested, there
is a functional cAMP response element on the renin pro-
moter [12]. Among all the intracellular second messengers
that control renin secretion, the cAMP signaling cascade
appears to be the core pathway for the exocytosis of renin
[10, 39, 40] (Fig. 3). Thus, prostaglandins, kinins, and b-
adrenergic agonists have a stimulatory effect on renin
release, in all cases because they increase cAMP generation
[41].
cAMP regulates a wide range of biological processes in
cells. The binding of an extracellular signal molecule to a
G-protein coupled receptor activates adenylyl cyclase
(AC), an enzyme that generates cAMP from ATP,
increasing its intracellular levels. This rise activates cAMP-
dependent protein kinase A (PKA). PKA translocates to the
nucleus to phosphorylate the gene regulatory protein
CREB (cAMP responsive element binding protein). CREB
recognizes a specific DNA sequence, called the cAMP
response element (CRE), found in the regulatory region of
many genes. Once phosphorylated, CREB recruits the
coactivator CBP (CREB-binding protein), which stimulates
gene transcription [42].
Interestingly, conditional deletion of G-protein subunits
in RPC has a great impact on their function. Indeed, mice
with protein Gsa (stimulatory subunit a) deficiency in JGC
have very low plasma renin concentrations, with resulting
low levels of aldosterone and arterial blood pressure.
Moreover, such deletion also resulted in abnormalities in
the preglomerular arterial tree [43, 44].
Elegant evidence on the regulation of renin production
by cAMP was obtained by Gomez et al., who labeled cells
of renin lineage with cyan fluorescent protein (CFP), and
cells producing renin with yellow fluorescent protein (YFP)
[45]. This yielded suitable amounts of cells which could
still produce renin after several passages. CFP-labeled cells
expressed VSMC markers like a-SMA and smooth muscle
myosin heavy chain (SM-MHC or Myh11), but not renin.
However, after stimulation with forskolin (an AC stimu-
lator) or cAMP analogs, they began to express YFP and
renin, and decreased a-SMA and Myh11 expression. This
response was even bigger with more intense or longer
stimuli, suggesting that the recruitment response is graded
[45].
7 Role of Calcium and cGMP
Calcium plays an important role in the biology of secretory
cells. In general, a rise in cytosolic calcium leads to the
release of their content. However, the opposite occurs in
parathyroid cells and JGC, where calcium inhibits renin
exocytosis. This is known as the ‘‘calcium paradox’’, and it
remained as a mystery for decades [41, 46].
JGC harbor 2 isoforms of AC (types V and VI), which
are inhibited by cytosolic calcium. Thus, particularly in
JGC, a decrease in cytosolic calcium would stimulate AC,
resulting in cAMP synthesis and, consequently, renin
release [47, 48]. Initially, it had been reported that calcium
inhibits renin gene transcription and destabilizes renin
mRNA [49]. More recently, it became clear that calcium
stimulates, via the calcium sensing receptor, a calcium
calmodulin-activated phosphodiesterase 1C (PDE1), an
enzyme that degradates cAMP, thereby providing an
additional explanation of the calcium paradox [50].
The contribution of cGMP to renin release is more
complex, with both stimulatory and inhibitory effects [46].
The cGMP and cAMP pathways are cross-linked. Nitric
oxide (NO) activates soluble guanylate cyclase (GC) to
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generate cGMP, which in turn inhibits phosphodiesterase 3,
a cAMP-degrading enzyme. Consequently, cAMP levels
will go up, and renin release will rise [46, 51]. However,
ligands that increase cGMP via activation of particulate GC
(like atrial natriuretic peptide) inhibit renin exocytosis
through activation of cGMP-dependent protein kinase type
II [10, 46]. Interestingly, Neubauer et al. recently demon-
strated that RPC recruitment is dependent on NO avail-
ability and the NO-GC signaling pathway [52].
8 Epigenetic Mechanisms and microRNA
(miRNA)
Acetylation and deacetylation of histones are important
epigenetics mechanisms involved in gene transcription
regulation. Acetylation is mediated by histone acetyl-
transferase (HAT), which leads to the transfer of an acetyl
functional group to histone molecules, promoting nucleo-
somal relaxation and transcriptional activation. Deacety-
lation is mediated by histone deacetylase (HDAC), and
results in chromatin condensation and transcriptional
repression [53].
Using the double-fluorescent reporter mouse model
described above, Gomez et al. observed that chromatin
remodeling contributes to the recruitment process, at the
cAMP level, through histone H4 acetylation [45]. The
underlying mechanism involved the CREB-recruited
cofactors CBP and p300, which exhibit HAT activity and,
in the CRE region, promote nucleosomal relaxation and,
consequently, transcriptional activation. In support of this
concept, forskolin increased histone H4 acetylation in the
CRE region [45]. Studies carried out in mice with condi-
tional deletion of CBP and p300 in RPC revealed that
individual deletion of one of these cofactors did not affect
renin expression, while simultaneous deletion reduced
renin in adult life, and resulted in renal interstitial fibrosis
[54]. CBP/p300 were also indispensable for re-expression
of renin in the arteriolar VSMC of mice exposed to low
sodium ? captopril [55]. Taken together, RPC have a
poised chromatin landscape suitable to respond properly to
threats, allowing these cells to switch the renin phenotype
on and off [33].
In addition to the epigenetic control mechanisms,
microRNAs (miRNAs) also control JGC activity. miRNAs
are endogenous small non-coding RNA molecules, con-
taining around 18–22 nucleotides. They exert their function
by targeting mRNA, inducing decay or translational
repression [56]. miRNA genes are phylogenetically con-
served, and are involved in many cell processes such as
Fig. 3 Simplified
scheme showing how cAMP
and cGMP regulate renin
(modified from [33]). ATP
adenosine-triphosphate, cAMP
cyclic adenosine-
monophosphate, AC adenylate
cyclase, CBP CREB-binding
protein, CREB cAMP response
element binding protein, cGMP
cyclic guanosine-
monophosphate, PDE
phosphodiesterase, NO nitric
oxide, pGC particulate
guanylate cyclase, sGC soluble
guanylate cyclase, GPRC
G-protein-coupled receptor, Gsa
stimulatory G protein a-subunit,
Gb inhibitory G protein b-
subunit, Gc inhibitory G protein
c-subunit, PKA protein kinase A
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developmental timing, death and proliferation [57].
miRNA transcription, usually by RNA polymerase II,
results in a long transcript, whose structure will be cleaved
by the RNase III endonuclease Drosha and the cofactor
DGCR8, yielding a miRNA precursor (pre-miRNA). This
precursor is processed by the RNase III enzyme Dicer, and
the product is incorporated into the RNA-induced silence
complex, where gene silencing proceeds [58].
Gomez et al. established the importance of Dicer for the
JGC and, even further, for the morphologic and physiologic
integrity of the kidney. They discovered that conditional
deletion of Dicer in cells of the renin lineage in mice
reduced the number of JGC and decreased renin gene
expression, thus leading to reduced plasma renin and blood
pressure levels. The animals also presented kidneys with
vascular abnormalities and striped fibrosis [59]. Notewor-
thy, this vascular pattern was quite similar to that found in
mice with ablation of the RPC, through the expression of
diphtheria toxin A chain driven by the renin promoter [20].
Surprisingly, kidney vessels exhibited normal wall thick-
ness and lumen size, in contrast to the concentric hyper-
trophy and thick vessel walls seen when RAS genes are
deleted, including renin. Apparently, RPC are responsible
for arterial wall thickening, by producing angiogenic and
trophic factors [20, 21].
Furthermore, Medrano et al. identified two miRNA,
miR-330 and miR-125b-5p, whose opposite actions are
crucial for the recruitment phenomenon. miR-125b-5p is
normally expressed in the VSMCs of the afferent arteriole,
and responsible for sustaining a contractile phenotype. Yet,
it is also expressed in JGC, in order to preserve their
contractile function. However, under a homeostasis threat,
miR-125b-5p expression diminishes in VSMC, allowing
them to undergo a metaplastic transformation into a renin
phenotype, and remains unaltered in JGC. miR-330 is
expressed in JGC only, and inhibits contractile features,
thus favoring renin production [60].
9 JGC Signature: The Myo-Endocrine Profile
Although several factors have been identified that regulate
renin production and secretion, RPC-specific markers were
limited to renin itself, and the gene Zis transcript [14]. To
overcome this problem, Brunskill et al. targeted YFP to
mouse JGC and used fluorescence-activated cell sorting
(FACS) to enrich tagged cells for transcriptome analysis.
This approach yielded a set of 369 core genes, responsible
for the JGC gene regulatory network [61]. Furthermore,
this distinct array of genes that governs JGC identity is
unique when compared to other cell types in the kidney.
Mainly, it encompasses genes highly expressed in both
smooth muscle and endocrine cells [61].
Among the genes identified in the transcriptome analy-
sis, renin was the highest transcribed gene. The second
highest one was aldo-keto reductase family 1, member B7
(Akr1b7), responsible for detoxification of steroidogenesis
products. Akr1b7 is a member of aldo-keto reductase
superfamily, which reduces harmful aldehydes and ketones
produced from the breakdown of lipid peroxides to their
respective alcohols [62]. Remarkably, despite its high
expression on JGC, mice with Akr1b7-deficient kidneys
had no abnormalities in renin production and secretion,
while renin deletion also did not affect Akr1b7 expression
[61, 63]. Therefore, Akr1b7 gene might function as a novel
JGC marker, independently of renin. Other highly expres-
sed transcripts involved genes related to the smooth muscle
phenotype, like a-SMA, Myh11 and calponin (Cnn1) [61].
Interestingly, the aforementioned genetic regulatory
network allows RPC to possess either an endocrine or a
contractile phenotype. Hence, this bivalent profile sustains
the ability of RPC to switch phenotype, depending on the
situation. Therefore, during a homeostasis challenge, renin
lineage cells have the gene program to differentiate into an
endocrine cell, synthesizing and releasing renin, in order to
reestablish the homeostasis. Moreover, due to their posi-
tion, at the glomerular hilum, JGC should also retain
contractile properties, allowing them to contract or relax
and, subsequently, to adjust renal blood flow and
glomerular filtration rate [33, 61].
Martini et al. performed RNA transcriptome analysis
on human reninomas, as an approach to further under-
stand JGC biology [64]. Reninomas are rare, renin-pro-
ducing tumors, arising from a proliferation of JGC in the
kidney cortex, and are often detected because of the
appearance of fulminant hypertension in young patients
[65, 66]. Deep sequencing of 4 human reninomas with
subsequent transcript mapping in the kidney of mice
under different conditions yielded a list of genes (36 of
which had never been described before) specifically
expressed in RPC. When evaluating 10 of these genes on
(pro)renin producing As4.1 cells, it was observed that
platelet-derived growth factor beta (PDGFB) suppressed
(pro)renin release and renin gene expression. Moreover,
PDGFB-exposed cells displayed a phenotypic shift from
myo-endocrine to inflammatory, evidenced by aSMA
downregulation and interleukin-6 upregulation, and a
more elongated shape (Fig. 4). Here it should be men-
tioned that neither conditional deletion of the PDGF
receptor in RPC, nor deletion of endothelial PDGFB
production affected the normal development of renal RPC
[67]. This may not be too surprising, given the fact that
PDGFB actually is a negative regulator of renin expres-
sion, possibly coming into play only under pathological
conditions. In summary, the reninoma data provide a
novel role for PDGFB as a regulator of RPC.
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10 Notch Signaling Pathway
The Notch signaling pathway is a highly conserved system,
present in all animal species, which plays a pivotal role in
local cell-cell communication, determining cell fate deci-
sions and controlling patterns formation during ontogene-
sis. Its dysfunction is linked to severe developmental
defects and pathologies [68]. The Notch signaling cascade
starts with the binding of specific ligands to the Notch
transmembrane receptor, leading to cleavage of the intra-
cellular Notch receptor domain (NIC). NIC translocates to
the nucleus, where it binds to RBPJ (recombination signal
binding protein for Ig-jJ region), a transcription factor that
normally represses Notch target genes by recruiting a co-
repressor complex. However, once it is coupled to NIC,
RBPJ recruits cofactors that activate the transcriptional
machinery [69].
Interestingly, among the 369 core genes that confer the
JGC identity according to the approach performed by
Brunskill et al., there are members of the Notch pathway,
including RBPJ [61]. In fact, RBPJ had already been
related to RPC plasticity by Castellanos Rivera et al. [70].
They generated a conditional knockout (cKO) of RBPJ in
renin lineage cells. This resulted in a striking reduction in
the JGC number and renin expression, with subsequently
low plasma renin levels and a low blood pressure. Fur-
thermore, under conditions that trigger the recruitment
phenomenon, such as sodium depletion and captopril
treatment, RBPJ-cKO mice were unable to exhibit renin
expression along the afferent arterioles, i.e., the ability of
their VSMCs to regain the renin phenotype was impaired.
Additionally, mice with RBPJ-cKO in renal cells of
FoxD1 lineage displayed significant renal abnormalities,
including a decline in the arteries and arterioles number, with
a thinner smooth muscle cell layer and renin depletion, fur-
ther upholding the concept that RBPJ is a major determinant
of the transformation of FoxD1 cells progenitors into a
healthy kidney vasculature [71]. Experiments in transgenic
renin reporter zebrafish fully support the essential role of the
Notch signaling pathway for developmental renin expression
and its association with proper angiogenesis [72].
RBPJ also has a pivotal role in the maintenance of the
JGC myo-endocrine gene program. Using a bacterial arti-
ficial chromosome reporter, it was observed that RBPJ
activates the renin promoter directly [15]. A double-fluo-
rescent mice reporter model subsequently revealed that
RBPJ deletion does not affect RPC endowment. RPC were
at their proper location, although unable to express renin
and Akr1b7, and, surprisingly, also did not express the
VSMC markers a-SMA, Myh11 and Cnn1. Yet, they dis-
played an upregulation of genes related to the immuno-
logical system, such as lipocalin-2, lysozyme-2, chemokine
ligand-9 and interleukin-6 [15]. Furthermore, Belyea et al.
identified renin progenitors in mouse bone marrow, and
found that in the presence of RPBJ-cKO in the renin cell
lineage, those progenitors gave rise to a very aggressive
lymphoblastic leukemia [73].
JGC are surrounded by multiple cell types, including
pericytes, endothelial cells, epithelial cells, VSMCs,
mesangial cells, and macula densa cells. Direct cell-to-cell
interaction will undoubtedly contribute to normal RPC
functioning. It is therefore not surprising that, among the
highly expressed transcripts identified by Brunskill et al. in
JGC, is connexin 40 [61]. Connexins are transmembrane
proteins, six of which assemble to mold a hemichannel.
When 2 hemichannels of adjacent cells align, a channel is
formed which allows the cytoplasma of both cells to con-
nect. A set of these channels in parallel builds a gap
junction, a structure that permits the cells to share small
molecules and, therefore, to respond to extracellular signals
in a coordinated way [16]. Unexpectedly, in mice lacking
connexin 40, RPC were found in the periglomerular
interstitium, and not at their normal juxtaglomerular loca-
tion. Besides, the recruitment phenomenon (following
severe sodium depletion) did not occur at its usual location,
Fig. 4 a Renin levels in medium obtained from renin-producing
As4.1 cells incubated for 48 h with medium derived from HEK293
cells transfected with platelet-derived growth factor beta (PDGFB).
Renin, a-smooth muscle actin (aSMA) and interleukin-6 (IL-6) gene
expression are also provided. Data (mean ± SEM of n = 5–11) are
modified from [64], and have been expressed as a percentage of the
levels in cells exposed to medium of control-transfected cells, i.e.,
cells treated with the transfection mix, but without cDNA. *P\ 0.05.
b, c As4.1 cells under control conditions and after exposure to
PDGFB (910 magnification)
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i.e., in the wall of the upstream preglomerular arterioles
[74]. Apparently therefore, cell-to-cell communication via
gap junctions is essential for the correct juxtaglomerular
positioning and recruitment of RPC.
11 Plasticity and Regeneration
More than 100 years have passed since renin’s discovery, and
the RAS now turns out to havemultiple effects beyond its role
in blood pressure regulation. As outlined in this review, renin
cells function as pluripotent progenitors for other kidney cells
types [32, 75]. Normally, a low perfusion pressure leads to an
expansion of RPC. Kurt et al. investigated to what degree this
relates to hypoxia per se, by deleting the von Hippel–Lindau
protein in JGC, i.e., the negative regulator of the hypoxia-
inducible transcriptional factor-2 (HIF-2a). Remarkably,
following the upregulation of HIF-2a by this procedure, RPC
started to express erythropoietin instead of renin, and the
normal renin upregulation after low saltwas no longer seen. In
fact, JGC were reprogrammed into fibroblast-like cells,
expressing collagen I and PDGF receptor b (PDGFR-b)
[76, 77]. Clearly therefore, hypoxia-inducible genes are
essential for normal development and physiologic adaptation
ofRPC.TheupregulatedPDGFR-b expression in these cells is
in full agreement with the results from the human reninoma
studies showing that the PDGFB-PDGFR-b pathway down-
regulates renin expression [64].
Pippin et al. proposed that cells of renin lineage present
alongside the preglomerular arteries participate in the
glomerular regeneration after podocyte injury [78]. In
support of this concept, renin cells from the juxta-
glomerular apparatus were shown to migrate to the
glomerular tuft, in order to replace podocytes [79]. This is
quite striking, since podocytes are normally derived from a
different embryonic structure, the cap mesenchyme cells.
Easier to understand is the participation of renin pro-
genitors in glomerular mesangium regeneration, since
mesangium cells, considered as specialized pericytes, are
derived from FoxD1 stromal cells present at the loose
mesenchyme. Indeed, in a mesangiolysis murine model,
renin lineage cells repopulated the intraglomerular
mesangium [80]. Interestingly, these cells stopped pro-
ducing renin and expressed PDGFR-b, i.e., the receptor
linked to renin downregulation [64]. Furthermore, Stefan-
ska et al. established that pericytes are RPC in the human
kidney [81]. Traditionally, pericytes are perivascular cells
that wrap around blood capillaries. They are highly plastic
cells contributing to multiple processes like angiogenesis,
tumorigenesis and vasculopathy progression [82]. The
concept that RPC are or derive from pericytes is very
interesting, since pericytes possess regenerative potential
and are additionally known for the fact that they express
the PDGFR-b [81]. In fact, in zebrafish, Rider et al.
observed that renin cells express this marker [83].
12 Concluding Remarks
How exactly renin cells are able to differentiate into many
different phenotypes remains to be clarified. The signals
allowingRPC to shift phenotype, or tomigrate to an injury site
are now only beginning to be unraveled. Many questions still
need to be answered, most importantly, whether regeneration
would eventually allow a restoration of normal function. This
is of particular relevance in chronic glomerulopathies, where
glomerular cells are destroyed, with subsequent overproduc-
tion of extracellular matrix, fibrosis and architectural disrup-
tion, all leading to physiological impairment. Apparently,
under such severe pathological conditions, tissue regeneration
by RPCs either does not occur of is insufficient. One possi-
bility is that RPCs under pathological conditions transform to
fibroblast-like cells, thus contributing to renal fibrosis them-
selves. Currently, RAS blockade is the cornerstone of renal
and cardiovascular diseases. Simultaneously, it is well known
that RAS blockers, like most anti-hypertensive drugs, induce
RPCs recruitment. The long-term effect of this chronic acti-
vation is still unknown, nor do we know to what degree it
contributes to (further) impairment of renal function. Detailed
knowledge of this process would lead to better treatment
options andmore favorable outcomes.Clearly, thiswhole area
not only illustrates the complexity of the renin cell, but also
represents an exciting new field that needs to be explored in
the coming years.
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